J&J to Supply EU with up to 400M Doses of its COVID-19 Vaccine

 J&J to Supply EU with up to 400M Doses of its COVID-19 Vaccine

J&J to Supply EU with up to 400M Doses of its COVID-19 Vaccine

Shots:

  • EC has approved an advance purchase agreement in which the Janssen will supply 200 M doses of the COVID-19 vaccine candidate to EU member states following approval from regulators. Additionally, the EU member states have an option to secure up to 200M additional doses
  • The agreement follows the conclusion of exploratory talks with the EC. Apart from the agreement, J&J plans to allocate up to 500M vaccine doses toward international efforts for ensuring access in lower income countries, with delivery beginning in mid-2021, following approval
  • J&J is evaluating a single dose regimen in P-III ENSEMBLE study initiated in Sept’2020 and plans the initiation of P-III study with a two-dose regimen later this year

    Click here ­to­ read full press release/ article | Ref: J&J | Image: Law.com

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post